ArticleMolecular oncology2019

FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells.

Carole Seguin-Devaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.